Skip to Main content Skip to Navigation
New interface
Conference papers

Multimodal nanovectors with a theranostic potential for cancer treatment

Abstract : Targeted theranosis (diagnosis combined to therapy) strategies are intended to improve cancer treatment efficacy while decreasing side effects. Nanovectors of hybrid (organic/inorganic) structure allow to combine multiple physical and biological functions and thus are being developed as promising contrast agents for multimodal diagnosis and drug nanocarriers for therapy of cancers. We present here three types of theranostic nanovectors our group develops, all based on combination of magnetic and optical properties with biological targeting and anticancer activity. Development of these nanovectors is being made in the frame of a multidisciplinary research, including biotechnology, chemical synthesis, pharmaceutical technology, physico-chemical and biological analysis in vitro and in vivo. The rational design of our nanovectors has been confirmed by complementary techniques as leading to promising biocompatibility and theranostic potential.
Document type :
Conference papers
Complete list of metadata

Cited literature [10 references]  Display  Hide  Download
Contributor : Nathalie Duchange Connect in order to contact the contributor
Submitted on : Monday, April 20, 2015 - 2:49:25 PM
Last modification on : Thursday, March 10, 2022 - 6:52:02 PM
Long-term archiving on: : Wednesday, April 19, 2017 - 12:27:02 AM


Files produced by the author(s)


Distributed under a Creative Commons Attribution 4.0 International License


  • HAL Id : inserm-01143905, version 1
  • PRODINRA : 312749


Ambre Carrouée, Christophe Alric, Stephanie David, Katel Hervé-Aubert, Nicolas Aubrey, et al.. Multimodal nanovectors with a theranostic potential for cancer treatment. Journées RITS 2015, Mar 2015, Dourdan, France. p14-15. ⟨inserm-01143905⟩



Record views


Files downloads